Examining Myddosome Formation by Luminescence-Based Mammalian Interactome Mapping (LUMIER)
Recent structural, biochemical, and functional studies have led to the notion that many of the post-receptor signaling complexes in innate immunity have a multimeric, multi-protein architecture whose hierarchical assembly is vital for function. The Myddosome is a post-receptor complex in the cytoplasmic signaling of Toll-like receptors (TLR) and the Interleukin-1 receptor (IL-1R), involving the proteins MyD88, IL-1R-associated kinase 4 (IRAK4), and IRAK2. Its importance is strikingly illustrated by the fact that rare germline mutations in MYD88 causing high susceptibility to infections are characterized by failure to assemble Myddosomes; conversely, gain-of-function MYD88 mutations leading to oncogenic hyperactivation of NF-κB show increased Myddosome formation. Reliable methods to probe Myddosome formation experimentally are therefore vital to further study the properties of this important post-receptor complex and its role in innate immunity, such as its regulation by posttranslational modification. Compared to structural and biochemical analyses, luminescence-based mammalian interactome mapping (LUMIER) is a straightforward, automatable, quantifiable, and versatile technique to study protein-protein interactions in a physiologically relevant context. We adapted LUMIER for Myddosome analysis and provide here a basic background of this technique, suitable experimental protocols, and its potential for medium-throughput screening. The principles presented herein can be adapted to other signaling pathways.
KeywordsToll-like receptor Myddosome Luminescence-based mammalian interactome mapping Renilla luciferase Protein-protein interactions Signaling complex
We thank Dr. Julie George and Dr. Hui Wang for contributing to the setup of LUMIER in our laboratory.
- 3.Motshwene PG, Moncrieffe MC, Grossmann JG, Kao CC, Ayaluru M, Sandercock AM, Robinson CV, Latz E, Gay NJ (2009) An oligomeric signalling platform formed by the toll-like receptor signal transducers MyD88 and IRAK4. J Biol Chem 284:25404. https://doi.org/10.1074/jbc.M109.022392. M109.022392 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
- 5.George J, Motshwene PG, Wang H, Kubarenko AV, Rautanen A, Mills TC, Hill AV, Gay NJ, Weber AN (2011) Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly. J Biol Chem 286(2):1341–1353. https://doi.org/10.1074/jbc.M110.159996. M110.159996 [pii]CrossRefPubMedGoogle Scholar
- 6.Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS, Shinjo F, Liu Y, Dembowy J, Taylor IW, Luga V, Przulj N, Robinson M, Suzuki H, Hayashizaki Y, Jurisica I, Wrana JL (2005) High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307(5715):1621–1625. https://doi.org/10.1126/science.1105776. 307/5715/1621 [pii]CrossRefPubMedGoogle Scholar
- 8.Avbelj M, Wolz OO, Fekonja O, Bencina M, Repic M, Mavri J, Kruger J, Scharfe C, Delmiro Garcia M, Panter G, Kohlbacher O, Weber AN, Jerala R (2014) Activation of lymphoma-associated MyD88 mutations via allostery-induced TIR-domain oligomerization. Blood 124(26):3896–3904. https://doi.org/10.1182/blood-2014-05-573188. blood-2014-05-573188 [pii]CrossRefPubMedPubMedCentralGoogle Scholar